FLETCHER PAYNE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Aptose Biosciences Inc.

Filing Date Source Excerpt
2024-07-17 If you have any questions or require assistance in voting your Shares, please call Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer, Chief Business Officer and Corporate Secretary, at 858-926-2730.
2024-12-30 If you have any questions or require assistance in voting your Shares, please call Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer, Chief Business Officer and Corporate Secretary, at 858-926-2730.

GYRE THERAPEUTICS, INC.

Filing Date Source Excerpt
2017-01-12 you may revoke your proxy by sending a notice of revocation to our Chief Financial Officer, Fletcher Payne ... The stockholder(s) hereby appoint(s) Nassim Usman and Fletcher Payne, or either of them, as proxies

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06